Yao-Min Hung

34PUBLICATIONS
36CO-AUTHORS
Molecular targetsNanomedicineCancer geneticsHaematological tumoursDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jul 03, 2026
Comparative risk of epilepsy with SGLT2 inhibitors versus incretin-based therapies in type 2 diabetes.

|Apr 30, 2026
Big Data Research: A Bridge From Basic Research to Clinical Trial Emulation.

|Nov 03, 2025
SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study.

Wan-Yin Cheng, Fu-Shun Yen, Yao-Min Hung

|Oct 07, 2025
SGLT2 Inhibitors and Prevention of Cardiovascular Events in Diabetes Patients with and Without Hypertension: A Nationwide Cohort Study.

Fu-Shun Yen, James Cheng-Chung Wei, Yao-Min Hung

|Aug 27, 2025
Impact of glucagon-like peptide-1 receptor agonists on the incidence of inflammatory bowel disease in people with type 2 diabetes.

Fu-Shun Yen, Shiow-Ing Wang, Yao-Min Hung

|May 30, 2025
Comparative Effectiveness of TNF-α and IL-6 Inhibitors on Bone Health Outcomes and Mortality in Rheumatoid Arthritis Patients: A Retrospective Cohort Study.

Hong Wang, Yun-Hen Lee, I-Han Cheng

Pageof 6

Frequent Collaborators

15 joint publications

Renin Chang

13 joint publications

James Cheng-Chung Wei

5 joint publications

Chii-Min Hwu

4 joint publications

Chih-Cheng Hsu